Health experts in Italy have made a significant breakthrough in cataract surgery, developing a new combination that prevents patients from experiencing discomfort after the procedure. According to Marcello Selvaggio, Global Head Business Franchise Ophthalmology at Ntc, the new combination has been exported to 90 countries worldwide. This development is a major success for Italy, Ntc, and Italian ophthalmologists.
The new combination was developed after conducting clinical research with major Italian ophthalmology clinics. The product has been distributed globally, with Ntc being the first Italian company to launch ophthalmic products on a global scale. Selvaggio made the announcement at the celebration of Ntc's tenth anniversary, where the company was recognized as one of the main players in European ophthalmology.
The new combination aims to prevent infections and inflammation problems that patients may experience after cataract surgery. This is a significant improvement in post-surgery care, as patients can now look forward to a more comfortable recovery. Ntc's achievement is a testament to the company's commitment to innovation and quality in ophthalmic products.
Ntc's global reach and success are evident in the fact that its products are now distributed in 90 countries. The company's tenth anniversary celebration in Milan brought together major players in European ophthalmology, highlighting Ntc's position as a leader in the field. Selvaggio expressed pride in the company's achievement, citing it as a great success for Italy and Italian ophthalmologists.
The development of the new combination is a result of Ntc's focus on research and innovation. The company's commitment to quality and patient care has enabled it to make a significant impact in the field of ophthalmology. With its products being used globally, Ntc is poised to continue making a difference in the lives of patients undergoing cataract surgery.
The new combination is a significant advancement in cataract surgery care, and its global distribution will benefit patients worldwide. Ntc's achievement serves as a model for other companies in the field, highlighting the importance of innovation and quality in the development of medical products. As the company continues to grow and expand its reach, it is likely to make an even greater impact in the field of ophthalmology.
The impact of Ntc's new combination on patients undergoing cataract surgery cannot be overstated. With the risk of discomfort and complications reduced, patients can now look forward to a more comfortable and successful recovery. As the company celebrates its tenth anniversary, it is clear that its commitment to innovation and quality has paid off, and its products will continue to make a difference in the lives of patients worldwide.
Key points
- A new combination developed by Italian health experts prevents discomfort after cataract surgery.
- The product has been exported to 90 countries worldwide.
- Ntc is the first Italian company to launch ophthalmic products on a global scale.
